B-1101
- Generic Name
- B-1101
A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism
Phase 2
Completed
- Conditions
- Acute Pulmonary Embolism
- Interventions
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2021-03-18
- Lead Sponsor
- Tasly Biopharmaceuticals Co., Ltd.
- Target Recruit Count
- 108
- Registration Number
- NCT03108833
- Locations
- 🇨🇳
The First Hospital of China Medical University, Shenyang, Liaoning, China
🇨🇳Fuwai Hospital, Beijing, Beijing, China
🇨🇳Anzhen Hospital, Capital Medical University, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath